Noncoding RNA and Ligamentum Flavum Degeneration
Author Information
Author(s): Zhao Yongzhao, Xiang Qian, Tian Shuo, Wu Zhenquan, Lin Jialiang, Wang Longjie, Sun Zhuoran, Li Weishi
Primary Institution: Peking University Third Hospital
Hypothesis
The role of noncoding RNAs in the degeneration of the ligamentum flavum and their potential as therapeutic targets.
Conclusion
Manipulating noncoding RNAs could provide new treatment options for degenerative spinal stenosis.
Supporting Evidence
- Noncoding RNAs are involved in the progression of several age-related diseases, including ligamentum flavum degeneration.
- Previous studies have shown that noncoding RNAs can regulate the osteogenic differentiation and fibrosis of ligamentum flavum cells.
- Identifying specific noncoding RNAs contributing to ligamentum flavum degeneration suggests potential treatment targets.
Takeaway
Noncoding RNAs are tiny molecules that help control how our genes work, and they might help us find new ways to treat back problems in older people.
Methodology
This review discusses the biological functions of noncoding RNAs in ligamentum flavum degeneration based on existing literature.
Limitations
The review does not provide human data or detailed mechanisms of noncoding RNA regulation in ligamentum flavum degeneration.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website